–CRISPR Therapeutics Gains Additional Rights to MaxCyte’s Cell Engineering Technology to Develop CRISPR/Cas9-Based Cell Therapies in Immuno-Oncology– ZUG, SWITZERLAND, CAMBRIDGE, MASS. and GAITHERSBURG, MD – CRISPR Therapeutics (NASDAQ:CRSP) and MaxCyte today announced the expansion of their existing relationship by entering into a non-exclusive commercial license agreement that will allow CRISPR Therapeutics to deploy MaxCyte’s Flow Electroporation® […]
Dolomite Bio, a leading provider of single cell technology, today launched a high throughput single nuclei RNA sequencing (sNuc-Seq) protocol for its Nadia Instrument. This latest addition to the Nadia application portfolio enables researchers to cost-effectively profile both complex and archived tissues with the goal of accelerating disease and drug discovery research in areas such […]
MANASSAS, Va. — Reinforcing its long-established reputation for quality and reliability as the steward for credible biomaterial and standards in the biological sciences, ATCC today announced details of its new initiative, Incredible 2020. Building on ATCC’s non-profit mission, this Incredible 2020 initiative, which was unveiled at the Society for Neuroscience (SfN) 2018 annual conference in San Diego, CA, […]
AMSBIO has expanded its range of high quality FFPE cancer cell line controls for immunohistochemistry (IHC), in situ hybridization (ISH) and Next Generation Sequencing (NGS) applications. Variations in FFPE tissue sample quality and experimental setup can lead to misleading results without reliable controls. Traditional cell or tissue-based control specimens often present intra specimen variation, lot-to-lot variations […]
With the goal of developing a novel immunotherapy for patients with glioblastoma, the research grant winner will employ xCELLigence Real Time Cell Analysis technology to develop armored CAR-T cells XCELLIGENCE IMMUNOTHERAPY RESEARCH GRANT WINNER DR. BRYAN CHOI IS A POSTDOCTORAL FELLOW WITH DR. MARCELA V. MAUS IN THE MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER AND […]
Precipio ICE COLD-PCR™ reagents will be sold with PerkinElmer DNA/RNA extraction and isolation products NEW HAVEN, CT – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced an agreement with PerkinElmer to jointly offer Precipio’s ICE COLD-PCR (ICP) mutation enrichment technology together with PerkinElmer’s NextPrep-Mag™ cell-free DNA isolation kit, Janus® G3 liquid handling workstation, and chemagic™ MSM […]
Specialized CRO offers high-definition tissue imaging services for pharmaceutical and clinical research SOUTH SAN FRANCISCO, Calif. and PORTLAND, Ore. — Sirona Dx, a leader in high-complexity genomics and proteomics services, today announced the introduction of Imaging Mass Cytometry™ services on the Fluidigm Hyperion™ Imaging System to advance biomarker discovery and therapeutic development. Sirona Dx is a specialized […]
The Olympus high-sensitivity SpinSR10 super resolution microscope combines fast 0.005 seconds/frame acquisition speed and 120-nanometer super resolution with improvements that provide clearer images and three times the brightness of the standard SpinSR10 model. Super resolution microscopes are used in medical and biological research to observe the internal structure of cells in fine detail, and brightness […]
Stratedigm is reinventing the way you design your automation experiments. With CellCapTure’s optional patent pending Visual Protocol Designer (VPD), users can easily create complex tasks and protocols to fully automate their experiments by utilizing a visual, drag-and-drop system. By utilizing “action blocks” for mixing, incubating, recording, and pipetting from well to well, users can now create novel […]
SAN DIEGOT Allele Biotechnology & Pharmaceuticals Inc. has received issuance notices from the U.S. Patent and Trademark Office for its first batch of patents covering the derivation of induced pluripotent stem cells (iPSCs). Allele’s proprietary technology uses only messenger RNA (mRNA) to reprogram human or other primate cells, avoiding many operational complications that other methods […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
